AwardTape · Defense awards · Medical · Drugs and biologicals · W91YTZ23C0010
W91YTZ23C0010: $360K definitive contract to Werfen USA LLC
Werfen USA LLC holds a definitive contract from Department of the Army with $360K obligated since Oct 2023, against a ceiling of $600K. Latest action Jun 4, 2026.
Fy24 new blood bank reagent-analzer eamc
| PIID | W91YTZ23C0010 |
|---|---|
| Type | definitive contract |
| Company | Werfen USA LLC |
| Agency | Department of the Army |
| Contracting office | W40M MRC0 WEST |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 334516 ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING |
| Obligated since Oct 2023 | $360K |
| Total obligated (lifetime) | $360K |
| Ceiling (base and all options) | $600K |
| Base date | Oct 1, 2023 |
| Latest action | Jun 4, 2026 |
| End date | Sep 30, 2028 |
| Actions since Oct 2023 | 8 |
| Pricing | Firm fixed price |
| Competition | Full and open competition |
| Place of performance | GA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial